Impact of combined MRP1 inhibition and mutant p53-targeting compound APR-246.

e14712Background: The tumor suppressor gene TP53 is the most frequently mutated gene in cancer. Mutant p53 protein is often expressed at high levels and accompanied with gain-of-function activities...